Eligibility for Anti-Amyloid Treatment
Dr. Gregg Day talks with Dr. Vijay Ramanan about the clinical trial eligibility criteria for lecanemab treatment for participants with early Alzheimer disease and the generalizability of anti-amyloid treatment.
Read the related article in Neurology.
Visit NPub.org/Podcast for associated article links.
You May Also Like
Speak with Power | Daily Confidence Boost
Motivation
Mental Gym Daily | Train Your Toughness
Motivation
High Value Male | Mindset for Men
Motivation
Choses à Savoir SANTE
Choses à Savoir
Be Calm and Relaxed with Rain and Thunder for Sleeping
ColoredJuice Podcast Studio
Métamorphose, éveille ta conscience !
Anne Ghesquière
HerbRally
Mason Hutchison
Inner Light
The Podcast Project
IN HINDZSIGHT
HINDZ
Guided Sleep Meditation & Sleep Hypnosis from Sleep Cove
Sleep Hypnosis, Meditations and Bedtime Stories
Speak with Power | Daily Confidence Boost
Motivation
Mental Gym Daily | Train Your Toughness
Motivation
High Value Male | Mindset for Men
Motivation
Choses à Savoir SANTE
Choses à Savoir
Be Calm and Relaxed with Rain and Thunder for Sleeping
ColoredJuice Podcast Studio
Métamorphose, éveille ta conscience !
Anne Ghesquière
HerbRally
Mason Hutchison
Inner Light
The Podcast Project
IN HINDZSIGHT
HINDZ
Guided Sleep Meditation & Sleep Hypnosis from Sleep Cove
Sleep Hypnosis, Meditations and Bedtime Stories
Community discussion